Literature DB >> 2649129

HLA class I gene expression on human primary tumours and autologous metastases: demonstration of selective losses of HLA antigens on colorectal, gastric and laryngeal carcinomas.

M A López-Nevot1, F Esteban, A Ferrón, J Gutiérrez, M R Oliva, C Romero, C Huelin, F Ruiz-Cabello, F Garrido.   

Abstract

The expression of HLA class I antigens was studied in 99 primary tumour (colorectal, gastric and laryngeal carcinomas) and 57 autologous metastases using immunohistological techniques and monoclonal antibodies against class I monomorphic determinants, HLA-B isotypic determinants and HLA polymorphic determinants. Fourteen per cent of colorectal, 9.6% of gastric and 20% of laryngeal carcinomas completely lacked class I molecules. Selective losses of HLA-B antigens were also detected in 8.8, 3.4 and 5.8% of these tumours respectively. Taking into account complete and selective loss of HLA-B the average alteration in the class I molecules expression totalled 21%. The comparison of class I expression between primary tumours and autologous metastases showed differences in 24% of the patients. These differences consisted mainly in a decrease of class I expression by metastases. Nevertheless, four types of divergence were detected in laryngeal carcinomas, namely: +/-, +/+, -/+, -/-. In addition, a clear correlation between degree of differentiation and class I expression was observed in laryngeal tumours. Finally, when class I gene RFLPs were compared with DNA from 15 tumours and autologous normal mucosa or peripheral lymphocytes, no differences were detected between these samples.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2649129      PMCID: PMC2246991          DOI: 10.1038/bjc.1989.45

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  40 in total

1.  MICRODROPLET ASSAY OF HUMAN SERUM CYTOTOXINS.

Authors:  P I TERASAKI; J D MCCLELLAND
Journal:  Nature       Date:  1964-12-05       Impact factor: 49.962

2.  H-2-like specificities of foreign haplotypes appearing on a mouse sarcoma after vaccinia virus infection.

Authors:  F Garrido; V Schirrmacher; H Festenstein
Journal:  Nature       Date:  1976-01-22       Impact factor: 49.962

3.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

4.  A general method for isolation of high molecular weight DNA from eukaryotes.

Authors:  N Blin; D W Stafford
Journal:  Nucleic Acids Res       Date:  1976-09       Impact factor: 16.971

5.  Further evidence for depression of H-2 and Ia-like specificities of foreign haplotypes in mouse tumour cell lines.

Authors:  F Garrido; H Festenstein; V Schirrmacher
Journal:  Nature       Date:  1976-06-24       Impact factor: 49.962

6.  Membrane molecules determined by the H-2 associated immune response region: isolation and some properties.

Authors:  S E Cullen; C S David; D C Shreffler; S G Nathenson
Journal:  Proc Natl Acad Sci U S A       Date:  1974-03       Impact factor: 11.205

7.  Ia antigen on peripheral blood mononuclear leukocytes in man. I. Expression, biosynthesis, and function of HLA-DR antigen non-T cells.

Authors:  E G Engleman; D J Charron; C J Benike; G J Stewart
Journal:  J Exp Med       Date:  1980-08-01       Impact factor: 14.307

8.  Major histocompatibility antigens: the human (HLA-A, -B, -C) and murine (H-2K, H-2D) class I molecules.

Authors:  H L Ploegh; H T Orr; J L Strominger
Journal:  Cell       Date:  1981-05       Impact factor: 41.582

9.  Absence of four H-2d antigenic specificites in an H-2d sarcoma.

Authors:  F Garrido; M Perez; M D Torres
Journal:  J Immunogenet       Date:  1979-04

10.  Independent regulation of H-2K and H-2D gene expression in murine teratocarcinoma somatic cell hybrids.

Authors:  R Gmür; D Solter; B B Knowles
Journal:  J Exp Med       Date:  1980-06-01       Impact factor: 14.307

View more
  30 in total

1.  Relationship between the downregulation of HLA class I antigen and clinicopathological significance in gastric cancer.

Authors:  Yu-Qing Shen; Jian-Qiong Zhang; Feng-Qing Miao; Jian-Min Zhang; Qin Jiang; Hao Chen; Xiang-Nian Shan; Wei Xie
Journal:  World J Gastroenterol       Date:  2005-06-21       Impact factor: 5.742

2.  Sporadic loss of leucocyte-function-associated antigen-3 (LFA-3) in colorectal carcinomas.

Authors:  K Koretz; P Schlag; P Möller
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

3.  Down-regulation of HLA-A mRNA in peripheral blood mononuclear cell of colorectal cancer.

Authors:  Ming-Chen Zhu; Yi-Jun Xu; Xiong Zou; Feng Yan
Journal:  Int J Colorectal Dis       Date:  2011-09-23       Impact factor: 2.571

Review 4.  The role of cytotoxic T-lymphocytes in the prevention and immune surveillance of tumors--lessons from normal and immunodeficient mice.

Authors:  I M Svane; M Boesen; A M Engel
Journal:  Med Oncol       Date:  1999-12       Impact factor: 3.064

5.  HLA antigens are candidate markers for prediction of lymph node metastasis in gastric cancer.

Authors:  K Ogoshi; T Tajima; T Mitomi; K Tsuji
Journal:  Clin Exp Metastasis       Date:  1996-05       Impact factor: 5.150

6.  HLA-DR expression is associated with excellent prognosis in squamous cell carcinoma of the larynx.

Authors:  F Esteban; F Ruiz-Cabello; A Concha; M Pérez-Ayala; J A Sánchez-Rozas; F Garrido
Journal:  Clin Exp Metastasis       Date:  1990 Jul-Aug       Impact factor: 5.150

7.  HLA class I alterations in breast carcinoma are associated with a high frequency of the loss of heterozygosity at chromosomes 6 and 15.

Authors:  María A Garrido; Teresa Rodriguez; Svitlana Zinchenko; Isabel Maleno; Francisco Ruiz-Cabello; Ángel Concha; Nicolás Olea; Federico Garrido; Natalia Aptsiauri
Journal:  Immunogenetics       Date:  2018-08-25       Impact factor: 2.846

8.  Quantification of HLA class I molecules on renal cell carcinoma using Edman degradation.

Authors:  Juliane S Stickel; Natalie Stickel; Jörg Hennenlotter; Karin Klingel; Arnulf Stenzl; Hans-Georg Rammensee; Stefan Stevanović
Journal:  BMC Urol       Date:  2011-01-20       Impact factor: 2.264

9.  Analysis of HLA class I expression in progressing and regressing metastatic melanoma lesions after immunotherapy.

Authors:  Rafael Carretero; José M Romero; Francisco Ruiz-Cabello; Isabel Maleno; Felix Rodriguez; Francisco M Camacho; Luis M Real; Federico Garrido; Teresa Cabrera
Journal:  Immunogenetics       Date:  2008-06-11       Impact factor: 2.846

10.  Expression of MHC class I and class II antigens in primary breast carcinomas and synchronous nodal metastases.

Authors:  A Maiorana; A M Cesinaro; R A Fano; G Collina
Journal:  Clin Exp Metastasis       Date:  1995-01       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.